Literature DB >> 25161116

Mild hyponatremia is associated with functional and cognitive decline in chronic hemodialysis patients.

Linda Shavit, Inga Mikeladze, Carmit Torem, Itzchak Slotki.   

Abstract

BACKGROUND: A high incidence and adverse outcomes of cognitive impairment in dialysis patients have recently become recognized. Classical risk factors, uremia, anemia, metabolic disturbances, and hemodynamic instability during dialysis accelerate vascular cognitive impairment. AIMS: To evaluate laboratory factors that influence cognitive function in consecutive chronic hemodialysis (CHD) patients over a 2-year period.
METHODS: Between June 2010 and June 2011 we conducted a prospective, single-center trial that evaluated cognitive function in adult chronic hemodialysis (HD) patients. A battery of cognitive function tests was used: modified mini mental state (3MS), trailmaking tests A (trails A) and B (trails B). The 15-item geriatric depression scale (GDS) and the activities of daily living (ADL) test were used, respectively, for assessing symptoms of depression and global functional status. All tests were performed twice at yearly intervals in consecutive HD patients. Global cognitive impairment was defined as a 3MS < 80 and impaired executive function as a Trails A performance time > 75 seconds and Trails B > 180 seconds.
RESULTS: 56 chronic HD patients aged 65.00 ± 17.8 years were studied; 57% of them were males. 86% suffered from hypertension (HTN), 40% were diabetics and ~ 1/3 had ischemic heart disease, congestive heart failure (CHF), and dyslipidemia. Average plasma calcium, phosphorus, and PTH were within the recommended range. No features suggestive of malnutrition, severe anemia, inflammation, or inadequate dialysis were detected. 14 patients (24%) had mild chronic hyponatremia (Na ranges 131 - 135 meq/L). Significant disturbances in global cognitive and executive function were detected in the study patients. In 2010, 50% had 3MS < 80, 71% and 91% had severely impaired trails A and B tests (respectively), 54% had symptoms of depression and 50% suffered from impaired ADL. Retesting of the survivors in 2011 revealed increased prevalence of cognitive and functional declines along with worsening depression scoring. Univariate analysis demonstrated significant correlation between cognitive decline and age, female gender, education, poor executive and functional status, inadequate dialysis dose (Kt/V < 1.2, p = 0.023), high plasma phosphorus levels (p > 6 mg/dL, p = 0.034), and hyponatremia (Na < 135 mEq/L, p = 0.001). Multivariate stepwise logistic regression analysis revealed statistically significant associations between hyponatremia and impaired ADL (p = 0.043) and impaired ADL and mortality (p = 0.002).
CONCLUSIONS: A high prevalence of global cognitive and executive impairment was detected in our hemodialysis cohort. We found an association between mild chronic hyponatremia and impaired functional status. Whether treatments aimed at modifying hyponatremia could mitigate functional decline or mortality remains to be elucidated.

Entities:  

Mesh:

Year:  2014        PMID: 25161116     DOI: 10.5414/CN108335

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  12 in total

1.  Serum Sodium and Cognition in Older Community-Dwelling Men.

Authors:  Kristen L Nowak; Kristine Yaffe; Eric S Orwoll; Joachim H Ix; Zhiying You; Elizabeth Barrett-Connor; Andrew R Hoffman; Michel Chonchol
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-08       Impact factor: 8.237

2.  Serum phosphate and cognitive function in older men.

Authors:  Yelena Slinin; Tien Vo; Brent C Taylor; Anne M Murray; John Schousboe; Lisa Langsetmo; Kristine Ensrud
Journal:  Int J Geriatr Psychiatry       Date:  2017-03-22       Impact factor: 3.485

3.  Hyponatremia and Cognitive Impairment in Patients Treated with Peritoneal Dialysis.

Authors:  Rong Xu; Hai-chen Pi; Zu-ying Xiong; Jin-lan Liao; Li Hao; Gui-ling Liu; Ye-Ping Ren; Qin Wang; Zhao-xia Zheng; Li-ping Duan; Jie Dong
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-31       Impact factor: 8.237

Review 4.  Nutrition and Cognition in Older Adults With Heart Failure: A Systematic Review.

Authors:  Mara W Stewart; Abigail C Traylor; Lisa C Bratzke
Journal:  J Gerontol Nurs       Date:  2015-11       Impact factor: 1.254

5.  Performance of the Modified Mini-Mental State Examination (3MS) in Assessing Specific Cognitive Function in Patients Undergoing Peritoneal Dialysis.

Authors:  Yi Li; Xue Tian; Zu-Ying Xiong; Jin-Lan Liao; Li Hao; Gui-Ling Liu; Ye-Ping Ren; Qin Wang; Li-Ping Duan; Zhao-Xia Zheng; Wen-Xiang Quan; Jie Dong
Journal:  PLoS One       Date:  2016-12-02       Impact factor: 3.240

6.  Asymptomatic hyponatremia: is it time to abandon this entity?

Authors:  Manjunath Kulkarni; Archana Bhat
Journal:  J Nephropharmacol       Date:  2015-03-10

7.  Associations between small and middle molecules clearance and the change of cognitive function in peritoneal dialysis.

Authors:  Yi Li; Hai-Chen Pi; Zhi-Kai Yang; Jie Dong
Journal:  J Nephrol       Date:  2019-10-23       Impact factor: 3.902

8.  An association of cognitive impairment with diabetes and retinopathy in end stage renal disease patients under peritoneal dialysis.

Authors:  Jin-Lan Liao; Zu-Ying Xiong; Zhi-Kai Yang; Li Hao; Gui-Ling Liu; Ye-Ping Ren; Qin Wang; Li-Ping Duan; Zhao-Xia Zheng; Jie Dong
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

9.  Executive function in end-stage renal disease: Acute effects of hemodialysis and associations with clinical factors.

Authors:  María Del Mar Sánchez-Fernández; Gustavo A Reyes Del Paso; José Manuel Gil-Cunquero; María José Fernández-Serrano
Journal:  PLoS One       Date:  2018-09-04       Impact factor: 3.240

10.  Pre-dialysis Hyponatremia and Change in Serum Sodium Concentration During a Dialysis Session Are Significant Predictors of Mortality in Patients Undergoing Hemodialysis.

Authors:  Kiichiro Fujisaki; Nobuhiko Joki; Shigeru Tanaka; Eiichiro Kanda; Takayuki Hamano; Ikuto Masakane; Kazuhiko Tsuruya
Journal:  Kidney Int Rep       Date:  2020-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.